Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
暂无分享,去创建一个
[1] Jeremy P. Sauer,et al. Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles , 2014, Nature Medicine.
[2] Donghong Zhao,et al. Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy , 2014, ACS nano.
[3] Zhe Wang,et al. Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. , 2013, Angewandte Chemie.
[4] Jianghong Rao,et al. Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. , 2014, Small.
[5] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[6] David L Porter,et al. Chimeric antigen receptor therapy for cancer. , 2014, Annual review of medicine.
[7] Yeonkyung Lee,et al. New paradigm for tumor theranostic methodology using bacteria-based microrobot , 2013, Scientific Reports.
[8] Funda Meric-Bernstam,et al. Overcoming implementation challenges of personalized cancer therapy , 2012, Nature Reviews Clinical Oncology.
[9] Paola Nicolussi,et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents , 2012, Proceedings of the National Academy of Sciences.
[10] Vladimir P Torchilin,et al. On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles , 2014, Nature Medicine.
[11] Ralph Weissleder,et al. A macrophage-targeted theranostic nanoparticle for biomedical applications. , 2006, Small.
[12] Simon R. Cherry,et al. A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin , 2014, Nature Communications.
[13] Raymond A. Firestone,et al. Lessons from 54 years of pharmaceutical research , 2011, Nature Reviews Drug Discovery.
[14] Raphael Sandaltzopoulos,et al. Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo , 2013, Cancer Immunology Research.
[15] Sonke Svenson,et al. Theranostics: are we there yet? , 2013, Molecular pharmaceutics.
[16] Martin Fussenegger,et al. A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device. , 2014, Molecular cell.
[17] Jibin Song,et al. Self-assembled plasmonic vesicles of SERS-encoded amphiphilic gold nanoparticles for cancer cell targeting and traceable intracellular drug delivery. , 2012, Journal of the American Chemical Society.
[18] Shoji Takeuchi,et al. Metre-long cell-laden microfibres exhibit tissue morphologies and functions. , 2013, Nature materials.
[19] Martin Fussenegger,et al. Reward-based hypertension control by a synthetic brain–dopamine interface , 2013, Proceedings of the National Academy of Sciences.
[20] Tayyaba Hasan,et al. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates , 2014, Proceedings of the National Academy of Sciences.
[21] He Tian,et al. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug. , 2014, Journal of the American Chemical Society.
[22] Peter L. Choyke,et al. Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe , 2011, Science Translational Medicine.
[23] R. Shah,et al. Personalized medicine: is it a pharmacogenetic mirage? , 2012, British journal of clinical pharmacology.
[24] Theresa M Reineke,et al. Theranostics: combining imaging and therapy. , 2011, Bioconjugate chemistry.
[25] Markus Wieland,et al. Programmable single-cell mammalian biocomputers , 2012, Nature.
[26] Huangxian Ju,et al. A multifunctional nanomicelle for real-time targeted imaging and precise near-infrared cancer therapy. , 2014, Angewandte Chemie.
[27] C. Lagenaur,et al. Role of CD47 as a marker of self on red blood cells. , 2000, Science.
[28] Martin Fussenegger,et al. Self-sufficient control of urate homeostasis in mice by a synthetic circuit , 2010, Nature Biotechnology.
[29] Jonathan S. Dordick,et al. Radio-Wave Heating of Iron Oxide Nanoparticles Can Regulate Plasma Glucose in Mice , 2012, Science.
[30] A. Romaschin,et al. Theranostics in the growing field of personalized medicine: an analytical chemistry perspective. , 2014, Analytical chemistry.
[31] Huangxian Ju,et al. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer. , 2013, Journal of the American Chemical Society.
[32] Roberto Cattaneo,et al. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded , 2008, Nature Reviews Microbiology.
[33] Yuebing Zheng,et al. Towards rational design of multifunctional theranostic nanoparticles: what barriers do we need to overcome? , 2014, Nanomedicine.
[34] Michel Sadelain,et al. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells , 2012, Nature Biotechnology.
[35] D. Kirn,et al. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer , 2009, Nature Reviews Cancer.
[36] Zahi A. Fayad,et al. Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.
[37] Yasuteru Urano,et al. In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins. , 2014, Bioconjugate chemistry.
[38] Hisataka Kobayashi,et al. Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.
[39] Martin Fussenegger,et al. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome , 2012, Proceedings of the National Academy of Sciences.
[40] T. Maheswaran,et al. Theranostics: A treasured tailor for tomorrow , 2014, Journal of pharmacy & bioallied sciences.
[41] Rex A. Moats,et al. Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies , 2013, Science Translational Medicine.
[42] E. Lander,et al. Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.
[43] Youngmi Kim,et al. ROS-Responsive Activatable Photosensitizing Agent for Imaging and Photodynamic Therapy of Activated Macrophages , 2013, Theranostics.
[44] Benjamin Rhau,et al. Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal , 2014, Proceedings of the National Academy of Sciences.
[45] Martin Fussenegger,et al. Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant , 2014, Nature Communications.
[46] M. Fussenegger,et al. A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice , 2011, Science.
[47] Karen L Wooley,et al. Hierarchically assembled theranostic nanostructures for siRNA delivery and imaging applications. , 2012, Journal of the American Chemical Society.
[48] Xiaoqi Sun,et al. Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer , 2014, Advanced materials.
[49] Pui-Chi Lo,et al. A glutathione-activated phthalocyanine-based photosensitizer for photodynamic therapy. , 2014, Chemistry.
[50] Ralph Weissleder,et al. A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis. , 2010, Small.
[51] Masayuki Miura,et al. Selective ablation of β-galactosidase-expressing cells with a rationally designed activatable photosensitizer. , 2014, Angewandte Chemie.
[52] Jae Hong Lee,et al. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug. , 2013, Journal of the American Chemical Society.
[53] Wendell A. Lim,et al. Bacterial Virulence Proteins as Tools to Rewire Kinase Pathways in Yeast and Immune Cells , 2012, Nature.
[54] Martin Fussenegger,et al. A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice , 2013, Nature Communications.
[55] Aaron Fenster,et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans , 2011, Nature.
[56] G. Dai,et al. A Theranostic Small Interfering RNA Nanoprobe Protects Pancreatic Islet Grafts From Adoptively Transferred Immune Rejection , 2012, Diabetes.
[57] Keith M. Stantz,et al. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse , 2012, Cancer Nanotechnology.
[58] K. Hong,et al. Folate-based near-infrared fluorescent theranostic gemcitabine delivery. , 2013, Journal of the American Chemical Society.
[59] Christina D Smolke,et al. Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins , 2010, Science.
[60] Kwan Soo Hong,et al. An activatable theranostic for targeted cancer therapy and imaging. , 2014, Angewandte Chemie.
[61] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[62] N. Forbes. Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.
[63] R. Weiss,et al. Cancer Cells Multi-Input RNAi-Based Logic Circuit for Identification of Specific , 2011 .
[64] Ben Zhong Tang,et al. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. , 2014, Journal of the American Chemical Society.
[65] Jennifer Sturgis,et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.
[66] Takafumi Miyamoto,et al. Synthesizing biomolecule-based Boolean logic gates. , 2013, ACS synthetic biology.